Fidelity Investments
MBIO icon

Fidelity Investments’s Mustang Bio MBIO Stock Holding History

Fidelity Investments’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-62
Closed -$545 – 5538
2024
Q4 		$545 Sell
62
-141
-69% -$1.56K ﹤0.01% 4980
2024
Q3 		$2.39K Buy
203
+48
+31% +$794 ﹤0.01% 4772
2024
Q2 		$3.67K Buy
155
+9
+6% +$171 ﹤0.01% 4625
2024
Q1 		$7.61K Buy
146
+2
+1% +$127 ﹤0.01% 4369
2023
Q4 		$9.72K Hold
144
– – ﹤0.01% 4245
2023
Q3 		$14.8K Hold
144
– – ﹤0.01% 3958
2023
Q2 		$44.7K Hold
144
– – ﹤0.01% 3483
2023
Q1 		$39.6K Hold
144
– – ﹤0.01% 3551
2022
Q4 		$42.7K Hold
144
– – ﹤0.01% 3493
2022
Q3 		$51K Sell
144
-4
-3% -$1.85K ﹤0.01% 3482
2022
Q2 		$65K Buy
148
+1
+0.7% +$554 ﹤0.01% 3471
2022
Q1 		$111K Buy
+147
New +$121K ﹤0.01% 3412
2021
Q3 		– Hold
0
– – – 4758
2021
Q2 		– Hold
0
– – – 4622

Other funds holding MBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments's MBIO Position: Q1 2025 in Review

Fidelity Investments sold out of Mustang Bio (MBIO) in Q1 2025, closing a stake of 62 shares — an estimated $545 sold.

Fidelity Investments first reported a position in MBIO in Q1 2022 and held it in 12 quarters. The position peaked at $111K in Q1 2022. 16 funds tracked by Wall St. Rank hold MBIO as of Q1 2025.

  • Fidelity Investments reported no remaining Mustang Bio position as of Q1 2025 after selling out during the quarter.
  • Fidelity Investments sold 62 Mustang Bio shares in Q1 2025, an estimated $545.
  • Fidelity Investments first reported a position in Mustang Bio in Q1 2022 and held it in 12 quarters.
  • Fidelity Investments's Mustang Bio position peaked at $111K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.